Bell Investment Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.19K | Sell |
36
-21
| -37% | -$694 | ﹤0.01% | 1536 |
|
2025
Q1 | $2.29K | Buy |
57
+25
| +78% | +$1.01K | ﹤0.01% | 1260 |
|
2024
Q4 | $1.51K | Hold |
32
| – | – | ﹤0.01% | 1435 |
|
2024
Q3 | $1.69K | Sell |
32
-10
| -24% | -$528 | ﹤0.01% | 1418 |
|
2024
Q2 | $2.28K | Buy |
42
+8
| +24% | +$434 | ﹤0.01% | 1300 |
|
2024
Q1 | $2.38K | Hold |
34
| – | – | ﹤0.01% | 1277 |
|
2023
Q4 | $2.84K | Buy |
+34
| New | +$2.84K | ﹤0.01% | 1181 |
|
2023
Q3 | – | Sell |
-31
| Closed | -$1.01K | – | 1951 |
|
2023
Q2 | $1.01K | Hold |
31
| – | – | ﹤0.01% | 1600 |
|
2023
Q1 | $1.09K | Buy |
31
+19
| +158% | +$669 | ﹤0.01% | 1531 |
|
2022
Q4 | $550 | Buy |
+12
| New | +$550 | ﹤0.01% | 1771 |
|